Winship radiation oncologist Jeffrey Bradley, MD, FACR, FASTRO has been appointed the new interim chairman of the Emory University Department of Radiation Oncology.
Jeffrey Bradley, MD, FACR, FASTRO, has been appointed the new interim chairman of the Emory University Department of Radiation Oncology. Bradley, previously the executive vice chairman of the department, succeeds former Winship Cancer Institute (Winship) Executive Director Walter J. Curran, Jr., MD, FACR, FASCO who announced in October 2020 that he would be stepping down from his role as chair.
Bradley joined Winship in 2019 from Washington University School of Medicine in St. Louis where he served as the S. Lee Kling Endowed Professor of Radiation Oncology and clinical director of the Kling Proton Center. Among his many achievements, he led the effort to open the world's first single-room proton center at Washington University's Barnes-Jewish Hospital. He is a founding member of the Particle Therapy Oncology Group of North America and the chairman of the NRG Oncology Lung Cancer Committee. Since joining Winship, Bradley has been appointed the James W. Keller, MD Distinguished Professorship in Radiation Oncology in support of his research in innovative radiation therapy technologies such as proton beam therapy and stereotactic body radiation therapy.
"We appreciate Dr. Bradley for taking on this new interim position to support the Department of Radiation Oncology. I am excited to work together as we move forward," says Adam Marcus, PhD, interim executive director of Winship.
Bradley says, "I am honored to serve the Department of Radiation Oncology as the new interim chairman and I appreciate the opportunity to help lead the department as we continue to expand."
Curran, who served as chairman of the Department of Radiation Oncology for 13 years, established the department as a national leader in clinical care, research, and education. Under his leadership, the department gained a reputation as an early adopter of advanced radiation therapy treatment options, often being one of the first in the state to acquire new radiation therapy technologies. He led efforts to open the Emory Proton Therapy Center, exclusively operated by department faculty and staff, which treated over 400 patients in its first year, and expanded basic, translational, and clinical research during his tenure. In mid-January, the Department of Radiation Oncology appointed Curran as professor emeritus.
